- Home
- VKTX vs AXTA Comparison
VKTX vs AXTA Comparison
Compare VKTX & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- AXTA
- Stock Information
- Founded
- VKTX 2012
- AXTA 1910
- Country
- VKTX United States
- AXTA United States
- Employees
- VKTX N/A
- AXTA N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- AXTA Paints/Coatings
- Sector
- VKTX Health Care
- AXTA Consumer Discretionary
- Exchange
- VKTX Nasdaq
- AXTA Nasdaq
- Market Cap
- VKTX 7.2B
- AXTA 7.8B
- IPO Year
- VKTX 2015
- AXTA 2014
- Fundamental
- Price
- VKTX $49.58
- AXTA $40.30
- Analyst Decision
- VKTX Strong Buy
- AXTA Buy
- Analyst Count
- VKTX 10
- AXTA 12
- Target Price
- VKTX $109.80
- AXTA $42.45
- AVG Volume (30 Days)
- VKTX 6.8M
- AXTA 2.0M
- Earning Date
- VKTX 10-23-2024
- AXTA 10-30-2024
- Dividend Yield
- VKTX N/A
- AXTA N/A
- EPS Growth
- VKTX N/A
- AXTA 39.14
- EPS
- VKTX N/A
- AXTA 1.49
- Revenue
- VKTX N/A
- AXTA $5,262,100,000.00
- Revenue This Year
- VKTX N/A
- AXTA $3.88
- Revenue Next Year
- VKTX N/A
- AXTA $2.90
- P/E Ratio
- VKTX N/A
- AXTA $27.06
- Revenue Growth
- VKTX N/A
- AXTA 2.70
- 52 Week Low
- VKTX $10.51
- AXTA $30.40
- 52 Week High
- VKTX $99.41
- AXTA $40.91
- Technical
- Relative Strength Index (RSI)
- VKTX 31.07
- AXTA 67.82
- Support Level
- VKTX $62.50
- AXTA $39.31
- Resistance Level
- VKTX $70.41
- AXTA $40.91
- Average True Range (ATR)
- VKTX 5.16
- AXTA 0.74
- MACD
- VKTX -2.29
- AXTA 0.24
- Stochastic Oscillator
- VKTX 1.99
- AXTA 89.36
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific and Latin America.